Global Injectable Dermal Filler Market Research Report 2021

Global Injectable Dermal Filler Market Research Report 2021

Table of Contents
1 Injectable Dermal Filler Market Overview
1.1 Product Overview and Scope of Injectable Dermal Filler
1.2 Injectable Dermal Filler Segment by Type
1.2.1 Global Injectable Dermal Filler Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Hyaluronic Acid
1.2.3 Collagen
1.2.4 Artecoll
1.2.5 CaHA
1.2.6 Others
1.3 Injectable Dermal Filler Segment by Application
1.3.1 Injectable Dermal Filler Sales Comparison by Application: (2021-2027)
1.3.2 Specialist and Dermatology Clinic
1.3.3 Hospitals and Clinics
1.3.4 Others
1.4 Global Injectable Dermal Filler Market Size Estimates and Forecasts
1.4.1 Global Injectable Dermal Filler Revenue 2016-2027
1.4.2 Global Injectable Dermal Filler Sales 2016-2027
1.4.3 Injectable Dermal Filler Market Size by Region: 2016 Versus 2021 Versus 2027
2 Injectable Dermal Filler Market Competition by Manufacturers
2.1 Global Injectable Dermal Filler Sales Market Share by Manufacturers (2016-2021)
2.2 Global Injectable Dermal Filler Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Injectable Dermal Filler Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Injectable Dermal Filler Manufacturing Sites, Area Served, Product Type
2.5 Injectable Dermal Filler Market Competitive Situation and Trends
2.5.1 Injectable Dermal Filler Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Injectable Dermal Filler Players Market Share by Revenue
2.5.3 Global Injectable Dermal Filler Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injectable Dermal Filler Retrospective Market Scenario by Region
3.1 Global Injectable Dermal Filler Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Injectable Dermal Filler Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Injectable Dermal Filler Market Facts & Figures by Country
3.3.1 North America Injectable Dermal Filler Sales by Country
3.3.2 North America Injectable Dermal Filler Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Injectable Dermal Filler Market Facts & Figures by Country
3.4.1 Europe Injectable Dermal Filler Sales by Country
3.4.2 Europe Injectable Dermal Filler Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Injectable Dermal Filler Market Facts & Figures by Region
3.5.1 Asia Pacific Injectable Dermal Filler Sales by Region
3.5.2 Asia Pacific Injectable Dermal Filler Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Injectable Dermal Filler Market Facts & Figures by Country
3.6.1 Latin America Injectable Dermal Filler Sales by Country
3.6.2 Latin America Injectable Dermal Filler Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Injectable Dermal Filler Market Facts & Figures by Country
3.7.1 Middle East and Africa Injectable Dermal Filler Sales by Country
3.7.2 Middle East and Africa Injectable Dermal Filler Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Injectable Dermal Filler Historic Market Analysis by Type
4.1 Global Injectable Dermal Filler Sales Market Share by Type (2016-2021)
4.2 Global Injectable Dermal Filler Revenue Market Share by Type (2016-2021)
4.3 Global Injectable Dermal Filler Price by Type (2016-2021)
5 Global Injectable Dermal Filler Historic Market Analysis by Application
5.1 Global Injectable Dermal Filler Sales Market Share by Application (2016-2021)
5.2 Global Injectable Dermal Filler Revenue Market Share by Application (2016-2021)
5.3 Global Injectable Dermal Filler Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Allergan Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Galderma
6.2.1 Galderma Corporation Information
6.2.2 Galderma Description and Business Overview
6.2.3 Galderma Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Galderma Product Portfolio
6.2.5 Galderma Recent Developments/Updates
6.3 LG Life Sciences
6.3.1 LG Life Sciences Corporation Information
6.3.2 LG Life Sciences Description and Business Overview
6.3.3 LG Life Sciences Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.3.4 LG Life Sciences Product Portfolio
6.3.5 LG Life Sciences Recent Developments/Updates
6.4 Merz
6.4.1 Merz Corporation Information
6.4.2 Merz Description and Business Overview
6.4.3 Merz Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merz Product Portfolio
6.4.5 Merz Recent Developments/Updates
6.5 Medytox
6.5.1 Medytox Corporation Information
6.5.2 Medytox Description and Business Overview
6.5.3 Medytox Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Medytox Product Portfolio
6.5.5 Medytox Recent Developments/Updates
6.6 HUGEL
6.6.1 HUGEL Corporation Information
6.6.2 HUGEL Description and Business Overview
6.6.3 HUGEL Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.6.4 HUGEL Product Portfolio
6.6.5 HUGEL Recent Developments/Updates
6.7 Croma-Pharma GmbH
6.6.1 Croma-Pharma GmbH Corporation Information
6.6.2 Croma-Pharma GmbH Description and Business Overview
6.6.3 Croma-Pharma GmbH Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Croma-Pharma GmbH Product Portfolio
6.7.5 Croma-Pharma GmbH Recent Developments/Updates
6.8 Beijing IMEIK
6.8.1 Beijing IMEIK Corporation Information
6.8.2 Beijing IMEIK Description and Business Overview
6.8.3 Beijing IMEIK Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Beijing IMEIK Product Portfolio
6.8.5 Beijing IMEIK Recent Developments/Updates
6.9 Bloomage BioTechnology
6.9.1 Bloomage BioTechnology Corporation Information
6.9.2 Bloomage BioTechnology Description and Business Overview
6.9.3 Bloomage BioTechnology Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Bloomage BioTechnology Product Portfolio
6.9.5 Bloomage BioTechnology Recent Developments/Updates
6.10 Elravie (Humedix)
6.10.1 Elravie (Humedix) Corporation Information
6.10.2 Elravie (Humedix) Description and Business Overview
6.10.3 Elravie (Humedix) Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Elravie (Humedix) Product Portfolio
6.10.5 Elravie (Humedix) Recent Developments/Updates
6.11 Cleviel (Pharma Research Products)
6.11.1 Cleviel (Pharma Research Products) Corporation Information
6.11.2 Cleviel (Pharma Research Products) Injectable Dermal Filler Description and Business Overview
6.11.3 Cleviel (Pharma Research Products) Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Cleviel (Pharma Research Products) Product Portfolio
6.11.5 Cleviel (Pharma Research Products) Recent Developments/Updates
6.12 Haohai Biological Technology
6.12.1 Haohai Biological Technology Corporation Information
6.12.2 Haohai Biological Technology Injectable Dermal Filler Description and Business Overview
6.12.3 Haohai Biological Technology Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Haohai Biological Technology Product Portfolio
6.12.5 Haohai Biological Technology Recent Developments/Updates
6.13 Q.O.Fill (JW Pharmaceutical)
6.13.1 Q.O.Fill (JW Pharmaceutical) Corporation Information
6.13.2 Q.O.Fill (JW Pharmaceutical) Injectable Dermal Filler Description and Business Overview
6.13.3 Q.O.Fill (JW Pharmaceutical) Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Q.O.Fill (JW Pharmaceutical) Product Portfolio
6.13.5 Q.O.Fill (JW Pharmaceutical) Recent Developments/Updates
6.14 Teoxane
6.14.1 Teoxane Corporation Information
6.14.2 Teoxane Injectable Dermal Filler Description and Business Overview
6.14.3 Teoxane Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Teoxane Product Portfolio
6.14.5 Teoxane Recent Developments/Updates
6.15 Sinclair
6.15.1 Sinclair Corporation Information
6.15.2 Sinclair Injectable Dermal Filler Description and Business Overview
6.15.3 Sinclair Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Sinclair Product Portfolio
6.15.5 Sinclair Recent Developments/Updates
6.16 Suneva Medical
6.16.1 Suneva Medical Corporation Information
6.16.2 Suneva Medical Injectable Dermal Filler Description and Business Overview
6.16.3 Suneva Medical Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Suneva Medical Product Portfolio
6.16.5 Suneva Medical Recent Developments/Updates
6.17 Prollenium
6.17.1 Prollenium Corporation Information
6.17.2 Prollenium Injectable Dermal Filler Description and Business Overview
6.17.3 Prollenium Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Prollenium Product Portfolio
6.17.5 Prollenium Recent Developments/Updates
6.18 S&V Technologies GMBH
6.18.1 S&V Technologies GMBH Corporation Information
6.18.2 S&V Technologies GMBH Injectable Dermal Filler Description and Business Overview
6.18.3 S&V Technologies GMBH Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.18.4 S&V Technologies GMBH Product Portfolio
6.18.5 S&V Technologies GMBH Recent Developments/Updates
6.19 Luminera
6.19.1 Luminera Corporation Information
6.19.2 Luminera Injectable Dermal Filler Description and Business Overview
6.19.3 Luminera Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Luminera Product Portfolio
6.19.5 Luminera Recent Developments/Updates
6.20 Matex-Lab
6.20.1 Matex-Lab Corporation Information
6.20.2 Matex-Lab Injectable Dermal Filler Description and Business Overview
6.20.3 Matex-Lab Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Matex-Lab Product Portfolio
6.20.5 Matex-Lab Recent Developments/Updates
6.21 Caregen
6.21.1 Caregen Corporation Information
6.21.2 Caregen Injectable Dermal Filler Description and Business Overview
6.21.3 Caregen Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Caregen Product Portfolio
6.21.5 Caregen Recent Developments/Updates
6.22 CG Bio
6.22.1 CG Bio Corporation Information
6.22.2 CG Bio Injectable Dermal Filler Description and Business Overview
6.22.3 CG Bio Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.22.4 CG Bio Product Portfolio
6.22.5 CG Bio Recent Developments/Updates
6.23 BioPlus
6.23.1 BioPlus Corporation Information
6.23.2 BioPlus Injectable Dermal Filler Description and Business Overview
6.23.3 BioPlus Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.23.4 BioPlus Product Portfolio
6.23.5 BioPlus Recent Developments/Updates
6.24 SciVision Biotech
6.24.1 SciVision Biotech Corporation Information
6.24.2 SciVision Biotech Injectable Dermal Filler Description and Business Overview
6.24.3 SciVision Biotech Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.24.4 SciVision Biotech Product Portfolio
6.24.5 SciVision Biotech Recent Developments/Updates
6.25 Jingjia Medical
6.25.1 Jingjia Medical Corporation Information
6.25.2 Jingjia Medical Injectable Dermal Filler Description and Business Overview
6.25.3 Jingjia Medical Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.25.4 Jingjia Medical Product Portfolio
6.25.5 Jingjia Medical Recent Developments/Updates
6.26 BioScience
6.26.1 BioScience Corporation Information
6.26.2 BioScience Injectable Dermal Filler Description and Business Overview
6.26.3 BioScience Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.26.4 BioScience Product Portfolio
6.26.5 BioScience Recent Developments/Updates
6.27 Genoss
6.27.1 Genoss Corporation Information
6.27.2 Genoss Injectable Dermal Filler Description and Business Overview
6.27.3 Genoss Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.27.4 Genoss Product Portfolio
6.27.5 Genoss Recent Developments/Updates
6.28 Laboratory Thoscane LLC
6.28.1 Laboratory Thoscane LLC Corporation Information
6.28.2 Laboratory Thoscane LLC Injectable Dermal Filler Description and Business Overview
6.28.3 Laboratory Thoscane LLC Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.28.4 Laboratory Thoscane LLC Product Portfolio
6.28.5 Laboratory Thoscane LLC Recent Developments/Updates
6.29 Dr. Korman Laboratories
6.29.1 Dr. Korman Laboratories Corporation Information
6.29.2 Dr. Korman Laboratories Injectable Dermal Filler Description and Business Overview
6.29.3 Dr. Korman Laboratories Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.29.4 Dr. Korman Laboratories Product Portfolio
6.29.5 Dr. Korman Laboratories Recent Developments/Updates
6.30 Hyamax
6.30.1 Hyamax Corporation Information
6.30.2 Hyamax Injectable Dermal Filler Description and Business Overview
6.30.3 Hyamax Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.30.4 Hyamax Product Portfolio
6.30.5 Hyamax Recent Developments/Updates
6.31 Ingal LLC
6.31.1 Ingal LLC Corporation Information
6.31.2 Ingal LLC Injectable Dermal Filler Description and Business Overview
6.31.3 Ingal LLC Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.31.4 Ingal LLC Product Portfolio
6.31.5 Ingal LLC Recent Developments/Updates
6.32 Joonghun
6.32.1 Joonghun Corporation Information
6.32.2 Joonghun Injectable Dermal Filler Description and Business Overview
6.32.3 Joonghun Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.32.4 Joonghun Product Portfolio
6.32.5 Joonghun Recent Developments/Updates
6.33 Mesopharm LTD
6.33.1 Mesopharm LTD Corporation Information
6.33.2 Mesopharm LTD Injectable Dermal Filler Description and Business Overview
6.33.3 Mesopharm LTD Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.33.4 Mesopharm LTD Product Portfolio
6.33.5 Mesopharm LTD Recent Developments/Updates
6.34 IRA Lab
6.34.1 IRA Lab Corporation Information
6.34.2 IRA Lab Injectable Dermal Filler Description and Business Overview
6.34.3 IRA Lab Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.34.4 IRA Lab Product Portfolio
6.34.5 IRA Lab Recent Developments/Updates
6.35 Jetema
6.35.1 Jetema Corporation Information
6.35.2 Jetema Injectable Dermal Filler Description and Business Overview
6.35.3 Jetema Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.35.4 Jetema Product Portfolio
6.35.5 Jetema Recent Developments/Updates
6.36 ExoCoBio
6.36.1 ExoCoBio Corporation Information
6.36.2 ExoCoBio Injectable Dermal Filler Description and Business Overview
6.36.3 ExoCoBio Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.36.4 ExoCoBio Product Portfolio
6.36.5 ExoCoBio Recent Developments/Updates
6.37 CHA MEDITECH
6.37.1 CHA MEDITECH Corporation Information
6.37.2 CHA MEDITECH Injectable Dermal Filler Description and Business Overview
6.37.3 CHA MEDITECH Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.37.4 CHA MEDITECH Product Portfolio
6.37.5 CHA MEDITECH Recent Developments/Updates
6.38 Bohus BioTech
6.38.1 Bohus BioTech Corporation Information
6.38.2 Bohus BioTech Injectable Dermal Filler Description and Business Overview
6.38.3 Bohus BioTech Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.38.4 Bohus BioTech Product Portfolio
6.38.5 Bohus BioTech Recent Developments/Updates
6.39 BR PHARM
6.39.1 BR PHARM Corporation Information
6.39.2 BR PHARM Injectable Dermal Filler Description and Business Overview
6.39.3 BR PHARM Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.39.4 BR PHARM Product Portfolio
6.39.5 BR PHARM Recent Developments/Updates
6.40 Dongbang Medical
6.40.1 Dongbang Medical Corporation Information
6.40.2 Dongbang Medical Injectable Dermal Filler Description and Business Overview
6.40.3 Dongbang Medical Injectable Dermal Filler Sales, Revenue and Gross Margin (2016-2021)
6.40.4 Dongbang Medical Product Portfolio
6.40.5 Dongbang Medical Recent Developments/Updates
6.41 Bioxis pharmaceuticals
6.42 Bio Standard
7 Injectable Dermal Filler Manufacturing Cost Analysis
7.1 Injectable Dermal Filler Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Injectable Dermal Filler
7.4 Injectable Dermal Filler Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Injectable Dermal Filler Distributors List
8.3 Injectable Dermal Filler Customers
9 Injectable Dermal Filler Market Dynamics
9.1 Injectable Dermal Filler Industry Trends
9.2 Injectable Dermal Filler Growth Drivers
9.3 Injectable Dermal Filler Market Challenges
9.4 Injectable Dermal Filler Market Restraints
10 Global Market Forecast
10.1 Injectable Dermal Filler Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Injectable Dermal Filler by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Injectable Dermal Filler by Type (2022-2027)
10.2 Injectable Dermal Filler Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Injectable Dermal Filler by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Injectable Dermal Filler by Application (2022-2027)
10.3 Injectable Dermal Filler Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Injectable Dermal Filler by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Injectable Dermal Filler by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Injectable Dermal Filler Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Injectable Dermal Filler Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Injectable Dermal Filler Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Injectable Dermal Filler Covered in This Study
Table 5. Global Injectable Dermal Filler Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Injectable Dermal Filler Sales Share by Manufacturers (2016-2021)
Table 7. Global Injectable Dermal Filler Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Injectable Dermal Filler Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Injectable Dermal Filler Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Injectable Dermal Filler Manufacturing Sites and Area Served
Table 11. Manufacturers Injectable Dermal Filler Product Type
Table 12. Global Injectable Dermal Filler Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Injectable Dermal Filler by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Dermal Filler as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Injectable Dermal Filler Sales by Region (2016-2021) & (K Units)
Table 16. Global Injectable Dermal Filler Sales Market Share by Region (2016-2021)
Table 17. Global Injectable Dermal Filler Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Injectable Dermal Filler Sales by Country (2016-2021) & (K Units)
Table 19. North America Injectable Dermal Filler Sales Market Share by Country (2016-2021)
Table 20. North America Injectable Dermal Filler Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Injectable Dermal Filler Revenue Market Share by Country (2016-2021)
Table 22. Europe Injectable Dermal Filler Sales by Country (2016-2021) & (K Units)
Table 23. Europe Injectable Dermal Filler Sales Market Share by Country (2016-2021)
Table 24. Europe Injectable Dermal Filler Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Injectable Dermal Filler Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Injectable Dermal Filler Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Injectable Dermal Filler Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Injectable Dermal Filler Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Injectable Dermal Filler Revenue Market Share by Region (2016-2021)
Table 30. Latin America Injectable Dermal Filler Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Injectable Dermal Filler Sales Market Share by Country (2016-2021)
Table 32. Latin America Injectable Dermal Filler Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Injectable Dermal Filler Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Injectable Dermal Filler Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Injectable Dermal Filler Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Injectable Dermal Filler Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Injectable Dermal Filler Revenue Market Share by Country (2016-2021)
Table 38. Global Injectable Dermal Filler Sales (K Units) by Type (2016-2021)
Table 39. Global Injectable Dermal Filler Sales Market Share by Type (2016-2021)
Table 40. Global Injectable Dermal Filler Revenue (Million US$) by Type (2016-2021)
Table 41. Global Injectable Dermal Filler Revenue Share by Type (2016-2021)
Table 42. Global Injectable Dermal Filler Price (US$/Unit) by Type (2016-2021)
Table 43. Global Injectable Dermal Filler Sales (K Units) by Application (2016-2021)
Table 44. Global Injectable Dermal Filler Sales Market Share by Application (2016-2021)
Table 45. Global Injectable Dermal Filler Revenue (Million US$) by Application (2016-2021)
Table 46. Global Injectable Dermal Filler Revenue Share by Application (2016-2021)
Table 47. Global Injectable Dermal Filler Price (US$/Unit) by Application (2016-2021)
Table 48. Allergan Corporation Information
Table 49. Allergan Description and Business Overview
Table 50. Allergan Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Allergan Injectable Dermal Filler Product
Table 52. Allergan Recent Developments/Updates
Table 53. Galderma Corporation Information
Table 54. Galderma Description and Business Overview
Table 55. Galderma Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Galderma Injectable Dermal Filler Product
Table 57. Galderma Recent Developments/Updates
Table 58. LG Life Sciences Corporation Information
Table 59. LG Life Sciences Description and Business Overview
Table 60. LG Life Sciences Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. LG Life Sciences Injectable Dermal Filler Product
Table 62. LG Life Sciences Recent Developments/Updates
Table 63. Merz Corporation Information
Table 64. Merz Description and Business Overview
Table 65. Merz Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Merz Injectable Dermal Filler Product
Table 67. Merz Recent Developments/Updates
Table 68. Medytox Corporation Information
Table 69. Medytox Description and Business Overview
Table 70. Medytox Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Medytox Injectable Dermal Filler Product
Table 72. Medytox Recent Developments/Updates
Table 73. HUGEL Corporation Information
Table 74. HUGEL Description and Business Overview
Table 75. HUGEL Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. HUGEL Injectable Dermal Filler Product
Table 77. HUGEL Recent Developments/Updates
Table 78. Croma-Pharma GmbH Corporation Information
Table 79. Croma-Pharma GmbH Description and Business Overview
Table 80. Croma-Pharma GmbH Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Croma-Pharma GmbH Injectable Dermal Filler Product
Table 82. Croma-Pharma GmbH Recent Developments/Updates
Table 83. Beijing IMEIK Corporation Information
Table 84. Beijing IMEIK Description and Business Overview
Table 85. Beijing IMEIK Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Beijing IMEIK Injectable Dermal Filler Product
Table 87. Beijing IMEIK Recent Developments/Updates
Table 88. Bloomage BioTechnology Corporation Information
Table 89. Bloomage BioTechnology Description and Business Overview
Table 90. Bloomage BioTechnology Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Bloomage BioTechnology Injectable Dermal Filler Product
Table 92. Bloomage BioTechnology Recent Developments/Updates
Table 93. Elravie (Humedix) Corporation Information
Table 94. Elravie (Humedix) Description and Business Overview
Table 95. Elravie (Humedix) Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Elravie (Humedix) Injectable Dermal Filler Product
Table 97. Elravie (Humedix) Recent Developments/Updates
Table 98. Cleviel (Pharma Research Products) Corporation Information
Table 99. Cleviel (Pharma Research Products) Description and Business Overview
Table 100. Cleviel (Pharma Research Products) Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Cleviel (Pharma Research Products) Injectable Dermal Filler Product
Table 102. Cleviel (Pharma Research Products) Recent Developments/Updates
Table 103. Haohai Biological Technology Corporation Information
Table 104. Haohai Biological Technology Description and Business Overview
Table 105. Haohai Biological Technology Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Haohai Biological Technology Injectable Dermal Filler Product
Table 107. Haohai Biological Technology Recent Developments/Updates
Table 108. Q.O.Fill (JW Pharmaceutical) Corporation Information
Table 109. Q.O.Fill (JW Pharmaceutical) Description and Business Overview
Table 110. Q.O.Fill (JW Pharmaceutical) Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Q.O.Fill (JW Pharmaceutical) Injectable Dermal Filler Product
Table 112. Q.O.Fill (JW Pharmaceutical) Recent Developments/Updates
Table 113. Teoxane Corporation Information
Table 114. Teoxane Description and Business Overview
Table 115. Teoxane Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Teoxane Injectable Dermal Filler Product
Table 117. Teoxane Recent Developments/Updates
Table 118. Sinclair Corporation Information
Table 119. Sinclair Description and Business Overview
Table 120. Sinclair Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Sinclair Injectable Dermal Filler Product
Table 122. Sinclair Recent Developments/Updates
Table 123. Suneva Medical Corporation Information
Table 124. Suneva Medical Description and Business Overview
Table 125. Suneva Medical Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Suneva Medical Injectable Dermal Filler Product
Table 127. Suneva Medical Recent Developments/Updates
Table 128. Prollenium Corporation Information
Table 129. Prollenium Description and Business Overview
Table 130. Prollenium Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Prollenium Injectable Dermal Filler Product
Table 132. Prollenium Recent Developments/Updates
Table 133. S&V Technologies GMBH Corporation Information
Table 134. S&V Technologies GMBH Description and Business Overview
Table 135. S&V Technologies GMBH Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. S&V Technologies GMBH Injectable Dermal Filler Product
Table 137. S&V Technologies GMBH Recent Developments/Updates
Table 138. Luminera Corporation Information
Table 139. Luminera Description and Business Overview
Table 140. Luminera Injectable Dermal Filler Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Luminera Injectable Dermal Filler Product
Table 142. Luminera Recent Developments/Updates
Table 143. Matex-Lab Corporation Information
Table 144. Matex-La

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs